Stock Analysis
Emerson Electric Co. (EMR) Stock Analysis
Emerson Electric Co. (EMR) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Emerson Electric Co. (EMR) currently has an AIQ Score of 58/100, indicating a neutral setup. Momentum is the strongest factor at 71/100. Value is the weakest current factor at 49/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
EMR at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $163.11 |
| AIQ Score | 58/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $82.72B |
| P/E Ratio (TTM) | 32.17 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $1.28 |
| Revenue (quarter ended 2026-06-30) | $4.87B |
| Dividend Yield (TTM) | 1.50% |
| Beta | 1.24 |
| Volume | 3.92M |
| 52-week range | $122.64-$166.35 |
| RSI 14 | 61.76 |
| 50-Day SMA | $156.47 |
| 200-Day SMA | $146.34 |
| Analyst Price Target | $166.47 |
| Next Earnings | Nov 4, 2026 |
EMREmerson Electric Co.
Industrials / Industrial - Machinery
Low Priority
Above Peers
Latest quote
- Momentum71
- Value49
- Quality56
- Risk resilience59
- Sentiment61
EMR Stock Analysis Summary
Emerson Electric Co. (EMR) currently has an AIQ Score of 58/100, indicating a neutral setup. Momentum is the strongest factor at 71/100. Value is the weakest current factor at 49/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, EMR has AIQ Score of 58/100 with Momentum base of 71/100 and fading Value at 49/100. Wait for component alignment before adding exposure.
Momentum (71/100) leads while Value (49/100) lags. This cross-factor spread creates entry timing uncertainty.
Industrials · 1.65% stock move · EMR classified in Industrial - Machinery.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is EMR Bullish or Bearish Right Now?
EMR currently has a neutral overall setup. Momentum is the strongest factor at 71/100, while Value is weakest at 49/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 71/100.
- - Price is +4.25% above its 50-day SMA.
- - Analyst target implies +2.06% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (35 vs 3).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
EMR's Technical Analysis Consensus is currently Strong Buy, with 35 buy, 7 neutral, and 3 sell votes. EMR's 14-day RSI is 61.76, which places the stock in a constructive momentum range. EMR's beta is 1.24, indicating greater market sensitivity than the broad market.
What Changed in EMR?
The largest recent change in EMR is AIQ Score moving up by 0.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the EMR Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
EMR Decision Framework
Public evidence layers, setup checks, and risk context for Emerson Electric Co..
Emerson Electric Co. (EMR) Stock Analysis
Emerson Electric Co. has an AIQ Score of 58/100 in a Neutral regime. Momentum is strongest at 71/100. Beta is 1.21, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | EMR is in a Neutral AIQ regime with score 58/100. |
| Signal Conflict | The primary conflict is that momentum leads at 71/100 while value lags at 49/100. |
| Factor Evidence | Momentum 71/100 · Value 49/100 · Quality 56/100 · Risk 59/100 · Sentiment 61/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 71/100.
Momentum is 71/100 and RSI (14) is 61.8.
EMR is in a Neutral regime at 58/100.
Risk factor is 59/100 with beta 1.21 and annual volatility 31.72%.
Current conflict: momentum leads at 71/100 while value lags at 49/100.
EMR Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
EMR Fundamentals
EMR valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
EMR Technical Analysis
EMR technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
EMR Stock Catalysts
Track EMR earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
EMR Dividend Analysis
EMR dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
EMR Financial Data
EMR revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
EMR Risk Analysis
EMR volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
EMR Stock News
EMR stock news, market tone, recent headlines, and catalyst context.
EMR vs Industrial Machinery & Equipment Peers
Current peer cohort: EMR · ETN · FAST · FLS · FMC. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| EMR Current stock | 58/100 | 49/100 | 71/100 | 59/100 | 0.74 | 31.72% | Current |
| ETN Eaton | 36/100 | 38/100 | 8/100 | 51/100 | 0.21 | 39.85% | EMR vs ETN |
| FAST Fastenal | 64/100 | 30/100 | 74/100 | 74/100 | 0.78 | 24.46% | EMR vs FAST |
| FLS Flowserve | 51/100 | 62/100 | 38/100 | 60/100 | 0.82 | 50.49% | EMR vs FLS |
| FMC FMC Corporation | 39/100 | 75/100 | 24/100 | 35/100 | -1.72 | 81.91% | EMR vs FMC |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 21, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts3 recent quarterly periods are available for review.
Checked Oct 21, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching EMR
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for EMR
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
EMR Stock FAQ
What is EMR stock price today?
Emerson Electric Co.'s current stock price is $163.11. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is EMR bullish or bearish right now?
EMR's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is EMR's market cap?
EMR's market cap is $82.72B based on the latest completed market-close snapshot from Oct 21, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is EMR's current P/E ratio?
EMR's current P/E ratio is 32.17 based on the latest completed market-close snapshot from Oct 21, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is EMR's RSI?
EMR's 14-day RSI is 61.76 based on the latest completed market-close snapshot from Oct 21, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is EMR above its 50-day and 200-day moving averages?
EMR is 4.25% from its 50-day SMA and 11.46% from its 200-day SMA based on the latest completed market-close snapshot from Oct 21, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is EMR's next earnings date?
EMR's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does EMR pay a dividend?
EMR's dividend yield is 1.50% based on the latest completed market-close snapshot from Oct 21, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.